These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8131985)

  • 1. A novel inhibitor of cytochrome P450 BM3.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1993 Nov; 21(4):411S. PubMed ID: 8131985
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkane metabolism by cytochrome P450 BM3.
    Munro AW; Lindsay JG; Coggins JR
    Biochem Soc Trans; 1993 Nov; 21(4):412S. PubMed ID: 8131986
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of flavin reoxidation in P450 BM3 by diphenyliodonium chloride.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1996 Feb; 24(1):17S. PubMed ID: 8674653
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
    Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
    Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox characterisation of flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S628. PubMed ID: 9450056
    [No Abstract]   [Full Text] [Related]  

  • 7. Redox cycling by cytochrome P-450.
    Besse P; Modi S; Boyle JM; Roberts GC; Primrose WU
    Biochem Soc Trans; 1997 Nov; 25(4):S579. PubMed ID: 9450007
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification schemes for the constituent domains of cytochrome P450 BM3 in E. coli.
    Munro AW
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):316S. PubMed ID: 8224461
    [No Abstract]   [Full Text] [Related]  

  • 9. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
    Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
    Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
    [No Abstract]   [Full Text] [Related]  

  • 11. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
    Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
    Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
    [No Abstract]   [Full Text] [Related]  

  • 12. The interaction of eukaryotic cytochrome b5 with flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Noble MA; Turner KL; Chapman SK
    Biochem Soc Trans; 1998 Aug; 26(3):S212. PubMed ID: 9765931
    [No Abstract]   [Full Text] [Related]  

  • 13. NADPH oxidase activity of cytochrome P-450 BM3 and its constituent reductase domain.
    Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
    Biochim Biophys Acta; 1995 Oct; 1231(3):255-64. PubMed ID: 7578214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction.
    Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Nat Struct Biol; 1996 May; 3(5):414-7. PubMed ID: 8612070
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Turner KL; Chapman SK; Munro AW
    Biochem Soc Trans; 1998 Aug; 26(3):S213. PubMed ID: 9765932
    [No Abstract]   [Full Text] [Related]  

  • 16. On the domain structure of cytochrome P450 102 (BM-3): isolation and properties of a 45-kDa FAD/NADP domain.
    Black SD
    Biochem Biophys Res Commun; 1994 Aug; 203(1):162-8. PubMed ID: 8074651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resonance Raman spectroscopic studies on intact cytochrome P450 BM3.
    Munro AW; Lindsay JG; Coggins JR; MacDonald I; Smith WE; Rospendowski BN
    Biochem Soc Trans; 1994 Feb; 22(1):54S. PubMed ID: 8206282
    [No Abstract]   [Full Text] [Related]  

  • 18. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
    Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
    Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional saturation mutagenesis as an approach to identification of substrate specificity determinants in cytochrome P450 BM3.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1993 Nov; 21(4):409S. PubMed ID: 8131983
    [No Abstract]   [Full Text] [Related]  

  • 20. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
    Gonvindaraj S; Li H; Poulos TL
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.